DOSAGE AND SAFETY OF LONG-TERM SUPPRESSIVE ACYCLOVIR THERAPY FOR RECURRENT GENITAL HERPES

The Lancet

Volumn 331, Issue 8591, 1988, Pages 926-928

  Mindel, A ^a   Carney, O ^a   Freris, M ^c   Faherty, A ^a   Patou, G ^b   Williams, P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

GENITAL HERPES; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE;

ACYCLOVIR; ADMINISTRATION, ORAL; ADULT; BILIRUBIN; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEADACHE; HERPES GENITALIS; HUMAN; IMMUNOSUPPRESSION; MALE; PATIENT COMPLIANCE; RANDOM ALLOCATION; RECURRENCE; TABLETS; TIME FACTORS;

EID: 0023920992     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)91725-4     Document Type: Article

References (13)

1. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection
2. Suppression of frequently recurring genital herpes. A placebo controlled double blind trial of oral acyclovir
3. Prophylactic oral acyclovir in recurrent genital herpes
4. Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo controlled crossover study
5. Acyclovir prophylaxis of recurrent genital herpes: a randomised placebo controlled crossover study
6. Intravenous acyclovir treatment for primary genital herpes
7. A test of homogeneity for ordered alternatives
8. A test of homogeneity for ordered alternatives II
9. Clinical use of acyclovir
10. Monitoring the safety of antivirals—the example of the acyclovir experience
11. Oral acyclovir for episodic treatment of recurrent genital herpes
12. Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes